Factors associated with intentional and unintentional non-adherence to adjuvant endocrine therapy following breast cancer-Reference-Cited by-同舟云学术

Factors associated with intentional and unintentional non-adherence to adjuvant endocrine therapy following breast cancer

Published:2016-11-30 Issue:1 Volume:27 Page:e12601
ISSN:0961-5423
Container-title:European Journal of Cancer Care
language:en
Short-container-title:Eur J Cancer Care

Author:

Brett J.¹,Fenlon D.²,Boulton M.¹,Hulbert-Williams N.J.³,Walter F.M.⁴,Donnelly P.⁵,Lavery B.⁶,Morgan A.⁷,Morris C.⁷,Watson E.¹

Affiliation:

1. Faculty of Health and Life Sciences; Oxford Brookes University; Oxford UK

2. Faculty of Health Sciences; University of Southampton; Southampton UK

3. Department of Psychology; Chester Research Unit for the Psychology of Health (CRUPH); University of Chester; Chester UK

4. Primary Care Cancer Research; Lucy Cavendish College; Cambridge University; Cambridge UK

5. South Devon Healthcare NHS Foundation Trust; Torbay Hospital; Torquay UK

6. Cancer Services; Churchill Site; Oxford University; Hospitals Foundation NHS Trust; Oxford UK

7. Independent Cancer Patient Voice; London UK

Publisher

Wiley

Subject

Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ecc.12601/fullpdf

Reference56 articles.

1. Adherence to maintenance-phase antidepressant medication as a function of patient beliefs about medication;Aikens;Annals of Family Medicine,2005

2. Desvenlafaxine for the treatment of vasomotor symptoms associated with menopause: A double-blind, randomized, placebo-controlled trial of efficacy and safety;Archer;American Journal of Obstetrics and Gynecology,2009

3. Adherence to adjuvant therapy in post-menopausal breast cancer patients: A review;Banning;European Journal of Cancer Care,2012

4. Intramuscular depot medroxyprogesterone versus oral megestrol for the control of postmenopausal hot flashes in breast cancer patients: A randomized study;Bertelli;Annals of Oncology,2002

5. Psychometric properties of a modified Beliefs about Medicine Questionnaire (BMQ) for women taking adjuvant endocrine therapies (AET) following early-stage breast cancer;Brett;Health and Psychology,2016

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incorporation of emergent symptoms and genetic covariates improves prediction of aromatase inhibitor therapy discontinuation;JAMIA Open;2024-01-04

2. Beliefs about medicines’ association with endocrine therapy adherence in early breast cancer survivors in Croatia;Acta Pharmaceutica;2023-12-01

3. Feasibility of Symptom Monitoring During the First Year of Endocrine Therapy for Early Breast Cancer Using Patient-Reported Outcomes Collected via Smartphone App;JCO Oncology Practice;2023-11

4. Development of oral oncolytic nonadherence estimator (ORACLE): A pretreatment nonadherence risk assessment for oral oncolytics;Journal of Oncology Pharmacy Practice;2023-10-30

5. Randomized phase III trial evaluating motivational interviewing and text interventions to optimize adherence to breast cancer endocrine therapy (Alliance A191901): the GETSET protocol;Trials;2023-10-12